BioLife Solutions (NASDAQ: BLFS - Get Free Report) and Qiagen (NYSE: QGEN - Get Free Report) are bot

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc.

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

BioLife Solutions (NASDAQ: BLFS - Get Free Report) and IQVIA (NYSE: IQV - Get Free Report) are both

BioLife Solutions, Inc. (BLFS) came out with quarterly earnings of $0.04 per share, beating the Zack

Total revenue of $28.5 million, up 21% over Q2 2025 GAAP gross margin of 64% and non-GAAP adjusted g

Stephens & Co. analyst Helfey Hannah downgrades BioLife Solutions (NASDAQ:BLFS) from Overweig

NEW YORK CITY & NEW ORLEANS--(BUSINESS WIRE)--Former Attorney General of Louisiana Charles C. Foti,

Jefferies analyst Matthew Stanton downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Hold and

TD Cowen analyst Brendan Smith downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Hold and lo

RGEN's $1.5 billion BioLife acquisition aims to expand its cell therapy capabilities, adding biopres

HC Wainwright & Co. analyst Yi Chen downgrades BioLife Solutions (NASDAQ:BLFS) from Buy to Ne

Repligen NASDAQ: RGEN said it has signed a definitive agreement to acquire BioLife Solutions in a tr

$HAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of BioLife Solutions, Inc. (

NEW YORK, July 22, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde  with Monteverde & Ass

Shareholder Alert: Ademi LLP investigates whether BioLife Solutions, Inc. is obtaining a Fair Price

MILWAUKEE, July 22, 2026 /PRNewswire/ -- Ademi LLP is investigating BioLife (NASDAQ: BLFS) for possi

Halper Sadeh LLC, an investor rights law firm, is investigating the sale of BioLife Solutions, Inc.

Life sciences company Repligen Corporation (NASDAQ:RGEN) on Wednesday agreed to acquire cell process

Repligen to acquire BioLife Solutions for $1.5B to boost cell therapy bioprocessing capabilities and

NEW YORK--(BUSINESS WIRE)--Halper Sadeh LLC, an investor rights law firm, is investigating the sale

Repligen Corp said on ​Wednesday it would buy ‌BioLife Solutions in a cash-and-stock deal valued at

BioLife stockholders will receive $11.25 per share in cash and 0.1442 shares of Repligen common stoc

Fast-tracks Repligen's leadership and customer solution offering in high-growth cell therapy market

On May 28, 2026, BioLife Solutions Inc (BLFS) shares rose 3.1% to a current price of $25.25. This mo

BioLife Solutions, Inc. (BLFS) Q1 2026 Earnings Call Transcript

BioLife Solutions (NASDAQ:BLFS) sees FY2026 sales of $112.500 million-$115.000 million vs $111.058 m

BioLife Solns (NASDAQ:BLFS) reported quarterly earnings of $0.04 per share which beat the analyst co

Companies Reporting Before The Bell • Frontline (NYSE:FRO) is expected to report quarterly earnings

Companies Reporting Before The Bell • Indivior (NASDAQ:INDV) is expected to report quarterly earnin

  During the Friday's sesion, 157 stocks hit new 52-week lows.

  On Thursday, 128 companies set new 52-week lows.

Gainers Tango Therapeutics, Inc. (NASDAQ: TNGX) climbed 85.2% to $7.09 after gaining 11% on Tuesd

Companies Reporting Before The Bell • Warner Music Gr (NASDAQ:WMG) is likely to report quarterly ea

Companies Reporting Before The Bell • Nomad Foods (NYSE:NOMD) is projected to report quarterly earn

Companies Reporting Before The Bell • KVH Industries (NASDAQ:KVHI) is projected to report quarterly

Gainers

Gainers Fast Radius, Inc. (NASDAQ: FSRD) shares climbed 172% to $0.2769 after dipping 40% on Wedn

Companies Reporting Before The Bell • GCM Grosvenor (NASDAQ:GCMG) is likely to report quarterly ear

Gainers